News
In a first step toward FDA approval of kidney xenotransplantation, a living human with end-stage kidney disease may receive a ...
The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.
Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...
The memories and autonomy destroyed by Alzheimer’s disease continue to make it one of the greatest health challenges faced by ...
With technology/AI taking over administrative and repetitive tasks, human roles will shift towards more strategic, creative, ...
Doctors should provide high quality, evidence based care reflecting individual preferences and needs, regardless of weight, argue Juan Franco and colleagues Doctors have traditionally recommended ...
Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...
In a functioning system, the kind of placebo-controlled vaccine trials that Secretary Kennedy is calling for would never get past an IRB, much less progress to an IND application. Vaccines are being ...
As clinical research increasingly relies on RWD to enhance trial design and patient insights, tokenization has emerged as a ...
Blockchain in healthcare set to hit $252.7B by 2035, driven by data security, interoperability, and patient-centric ...
Lower-than-expected pregnancy loss following flu vaccine, however. HHS wants 18-month hold on FOIA litigation related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results